Toopi Organics
Active#23 worldwide · Biological inputsCollects human urine and turns it into microbial biostimulants and biofertilisers, using lactic bacteria fermentation to supply farmers with a partial replacement for mineral fertilisers.
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Biological inputs · worldwide | Top 32 | #23 | Edition 0 · Oct 2026 | 12 Feb 2027 |
Estimated valuation
AI · Biological inputs ranking (worldwide)- Anchor
- Last known equity round: Series A · USD 11.8M · Sep 2023
An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| Sep 2023 | Series A | USD 11.8M | Equity | VisVires New Protein, Edaphon, MAIF Impact, BNP Paribas Développement |
EUR 11M equity at ~1.07 USD/EUR (Sept 2023); total EUR 16M incl. ~EUR 5M non-dilutive excluded.
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Toopi Organics as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in biological inputs
Full biological inputs ranking →Investors in Toopi Organics: VisVires New Protein · Edaphon · MAIF Impact · BNP Paribas Développement
Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.